NPNRX
Price
$44.60
Change
-$1.15 (-2.51%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

NPNRX vs RMFCX

Header iconNPNRX vs RMFCX Comparison
Open Charts NPNRX vs RMFCXBanner chart's image
Neuberger Berman Large Cap Value R3
Price$44.60
Change-$1.15 (-2.51%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
NPNRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPNRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPNRX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. NPNRX (8.68B). NPNRX pays higher dividends than RMFCX: NPNRX (1.97) vs RMFCX (1.69). NPNRX was incepted earlier than RMFCX: NPNRX (15 years) vs RMFCX (23 years). NPNRX is a more actively managed with annual turnover of: 81.00 vs. RMFCX (25.00). NPNRX has a lower initial minimum investment than RMFCX: NPNRX (0) vs RMFCX (250). NPNRX annual gain was more profitable for investors over the last year : 14.05 vs. RMFCX (12.63). NPNRX return over 5 years is better than : 52.30 vs. RMFCX (40.39).
NPNRXRMFCXNPNRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD12.61711.423110%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.68B98.7B9%
Annual Yield % from dividends1.971.69116%
Returns for 1 year14.0512.63111%
Returns for 3 years11.7714.1683%
Returns for 5 years52.3040.39129%
Returns for 10 years46.2961.8475%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc